Potassium-Sparing Diuretics
(Redirected from Triamterene)
Potassium-Sparing Diuretics are a subclass of diuretics that do not promote the excretion of potassium, unlike other classes such as loop or thiazide diuretics. This category includes Amiloride, Eplerenone, Spironolactone, and Triamterene. These agents serve a critical role in the management of various medical conditions, primarily those associated with fluid retention.
Introduction
In general, diuretics promote the removal of excess fluid from the body by increasing urine production. However, many diuretics also cause the body to excrete potassium, leading to potential problems such as hypokalemia. The potassium-sparing diuretics, as their name suggests, are designed to counteract this problem.
Amiloride
Amiloride, a pyrazinoylguanidine derivative, acts on renal epithelial sodium channels, thereby promoting sodium excretion with minimal impact on potassium levels. This action results in its potassium-sparing feature. While similar in action to Triamterene, its chemical structure differs.
- Clinical Usage: It is used for edema management, especially when combined with thiazide diuretics. Given its modest diuretic effect, it's frequently paired with a thiazide diuretic, like hydrochlorothiazide in Moduretic, utilizing its potassium-sparing property to balance the potassium-wasting effect of thiazides.
- Adverse Effects: Side effects may include hyperkalemia, headache, dizziness, gastrointestinal upset, and rash.
- Availability and Dosage: Available generically and under the brand Midamor in 5 mg tablets. Typically, doses range from 5 to 20 mg daily.
Eplerenone
A competitive aldosterone antagonist, Eplerenone has a strong affinity for aldosterone receptors in the kidneys. This bond leads to sodium diuresis while preserving potassium levels, vital in conditions like hypertension and post-myocardial infarction heart failure.
- Clinical Usage: Primarily used for hypertension management and heart failure post-myocardial infarction.
- Adverse Effects: Eplerenone may cause hyperkalemia, transient increases in serum aminotransferase levels, and serum creatinine elevation.
- Availability and Dosage: Offered generically and under the brand name Inspra in 25 and 50 mg tablets. Initial doses are 25 or 50 mg daily, with maintenance doses between 25 and 100 mg daily.
Spironolactone
A well-established aldosterone antagonist, Spironolactone acts by inhibiting the mineralocorticoid receptor in the kidneys. Its ability to modulate sodium and potassium exchange makes it valuable for managing edematous states, especially those induced by hyperaldosteronism such as in cirrhosis.
- Clinical Usage: Predominantly used for edema management in conditions like cirrhosis, it's also combined with other diuretics to counterbalance their potassium-wasting effects.
- Adverse Effects: Its antiandrogen-like effects can lead to side effects like hair growth and gynecomastia.
- Availability and Dosage: Available under the brand Aldactone and generically in multiple strengths. Doses range from 25 mg daily up to 450 mg daily based on clinical need.
Triamterene
Triamterene targets sodium channels in the renal tubules, promoting sodium diuresis and retaining potassium. This action profile makes it a choice for edema management, often alongside other diuretics.
- Clinical Usage: Used in edema therapy, it can be safely prescribed for cirrhosis patients and combined with other diuretics to minimize hypokalemia risks.
- Adverse Effects: Common side effects encompass dizziness, fatigue, headache, dry mouth, and hyperkalemia.
- Availability and Dosage: Available as Dyrenium and generically in 50 and 100 mg tablets or capsules. Typical doses range between 50 and 200 mg daily.
Summary
Potassium-sparing diuretics hold a pivotal role in numerous therapeutic scenarios. Their ability to retain potassium while promoting diuresis makes them a preferred choice, especially when potassium imbalances are a concern.
This article is a medical stub. You can help WikiMD by expanding it! | |
---|---|
Diuretics (C03) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
[[Category:Diuretics]
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD